Literature DB >> 25921034

Role of CB2 receptors in social and aggressive behavior in male mice.

Marta Rodríguez-Arias1, Francisco Navarrete, M Carmen Blanco-Gandia, M Carmen Arenas, María A Aguilar, Adrián Bartoll-Andrés, Olga Valverde, José Miñarro, Jorge Manzanares.   

Abstract

RATIONALE: Male CB1KO mice exhibit stronger aggressive responses than wild-type mice.
OBJECTIVE: This study was designed to examine the role of cannabinoid CB2r in social and aggressive behavior.
METHODS: The social interaction test and resident-intruder paradigm were performed in mice lacking CB2r (CB2KO) and in wild-type (WT) littermates. The effects of the CB2r selective agonist JWH133 (1 and 2 mg/kg) on aggression were also evaluated in Oncins France 1 (OF1) mice. Gene expression analyses of monoamine oxidase-A (MAO-A), catechol-o-methyltransferase (COMT), 5-hydroxytryptamine transporter (5-HTT), and 5-HT1B receptor (5HT1Br) in the dorsal raphe nuclei (DR) and the amygdala (AMY) were carried out using real-time PCR.
RESULTS: Group-housed CB2KO mice exhibited higher levels of aggression in the social interaction test and displayed more aggression than resident WT mice. Isolation increased aggressive behavior in WT mice but did not affect CB2KO animals; however, the latter mice exhibited higher levels of social interaction with their WT counterparts. MAO-A and 5-HTT gene expression was significantly higher in grouped CB2KO mice. The expression of 5HT1Br, COMT, and MAO-A in the AMY was more pronounced in CB2KO mice than in WT counterparts. Acute administration of the CB2 agonist JWH133 significantly reduced the level of aggression in aggressive isolated OF1 mice, an effect that decreased after pretreatment with the CB2 receptor antagonist AM630.
CONCLUSION: Our results suggest that CB2r is implicated in social interaction and aggressive behavior and deserves further consideration as a potential new target for the management of aggression.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25921034     DOI: 10.1007/s00213-015-3939-5

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  49 in total

1.  The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety.

Authors:  J Haller; N Bakos; M Szirmay; C Ledent; T F Freund
Journal:  Eur J Neurosci       Date:  2002-10       Impact factor: 3.386

2.  Differential regulation of catechol-O-methyltransferase expression in a mouse model of aggression.

Authors:  Stephen D Ginsberg; Shaoli Che; Audrey Hashim; Jiri Zavadil; Robert Cancro; Sang H Lee; Eva Petkova; Henry W Sershen; Jan Volavka
Journal:  Brain Struct Funct       Date:  2011-04-22       Impact factor: 3.270

Review 3.  Biosocial studies of antisocial and violent behavior in children and adults: a review.

Authors:  Adrian Raine
Journal:  J Abnorm Child Psychol       Date:  2002-08

4.  Chronic blockade of cannabinoid CB2 receptors induces anxiolytic-like actions associated with alterations in GABA(A) receptors.

Authors:  María S García-Gutiérrez; Borja García-Bueno; Silvia Zoppi; Juan C Leza; Jorge Manzanares
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

5.  Marihuana and shock induced aggression in rats.

Authors:  B Carder; J Olson
Journal:  Physiol Behav       Date:  1972-04

6.  Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour.

Authors:  Mauro Maccarrone; Olga Valverde; Maria L Barbaccia; Anna Castañé; Rafael Maldonado; Catherine Ledent; Marc Parmentier; Alessandro Finazzi-Agrò
Journal:  Eur J Neurosci       Date:  2002-04       Impact factor: 3.386

7.  Neuropsychobiological evidence for the functional presence and expression of cannabinoid CB2 receptors in the brain.

Authors:  Emmanuel S Onaivi
Journal:  Neuropsychobiology       Date:  2007-03-15       Impact factor: 2.328

8.  Association of low-activity MAOA allelic variants with violent crime in incarcerated offenders.

Authors:  Dean A Stetler; Chad Davis; Kathryn Leavitt; Ilana Schriger; Katie Benson; Samir Bhakta; Lam Chee Wang; Cynthia Oben; Matthew Watters; Tara Haghnegahdar; Marco Bortolato
Journal:  J Psychiatr Res       Date:  2014-07-17       Impact factor: 4.791

9.  Novel monoamine oxidase A knock out mice with human-like spontaneous mutation.

Authors:  Anna L Scott; Marco Bortolato; Kevin Chen; Jean C Shih
Journal:  Neuroreport       Date:  2008-05-07       Impact factor: 1.837

10.  CB1 cannabinoid receptor-mediated aggressive behavior.

Authors:  Marta Rodriguez-Arias; Francisco Navarrete; Manuel Daza-Losada; Daniela Navarro; María A Aguilar; Pere Berbel; José Miñarro; Jorge Manzanares
Journal:  Neuropharmacology       Date:  2013-08-02       Impact factor: 5.250

View more
  7 in total

Review 1.  The endocannabinoid system as a target for novel anxiolytic drugs.

Authors:  Sachin Patel; Mathew N Hill; Joseph F Cheer; Carsten T Wotjak; Andrew Holmes
Journal:  Neurosci Biobehav Rev       Date:  2017-05       Impact factor: 8.989

2.  Social Isolation Alters Social and Mating Behavior in the R451C Neuroligin Mouse Model of Autism.

Authors:  E L Burrows; A F Eastwood; C May; S C Kolbe; T Hill; N M McLachlan; L Churilov; A J Hannan
Journal:  Neural Plast       Date:  2017-01-31       Impact factor: 3.599

Review 3.  CB2 Receptor Involvement in the Treatment of Substance Use Disorders.

Authors:  Francisco Navarrete; María S García-Gutiérrez; Ani Gasparyan; Daniela Navarro; Jorge Manzanares
Journal:  Biomolecules       Date:  2021-10-20

4.  Endocannabinoids and Precision Medicine for Mood Disorders and Suicide.

Authors:  Graziano Pinna
Journal:  Front Psychiatry       Date:  2021-05-20       Impact factor: 4.157

Review 5.  Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders.

Authors:  Gemma Navarro; Paula Morales; Carmen Rodríguez-Cueto; Javier Fernández-Ruiz; Nadine Jagerovic; Rafael Franco
Journal:  Front Neurosci       Date:  2016-09-13       Impact factor: 4.677

6.  5-HT2CR antagonist/5-HT2CR inverse agonist recovered the increased isolation-induced aggressive behavior of BALB/c mice mediated by ADAR1 (p110) expression and Htr2c RNA editing.

Authors:  Weizhi Yu; Hong Xu; Ying Xue; Dong An; Huairui Li; Wei Chen; Deqin Yu; Yiping Sun; Jianmei Ma; Yiyuan Tang; Zhaoyang Xiao; Shengming Yin
Journal:  Brain Behav       Date:  2018-02-07       Impact factor: 2.708

Review 7.  The Endocannabinoid System, Aggression, and the Violence of Synthetic Cannabinoid Use, Borderline Personality Disorder, Antisocial Personality Disorder, and Other Psychiatric Disorders.

Authors:  Nathan J Kolla; Achal Mishra
Journal:  Front Behav Neurosci       Date:  2018-03-27       Impact factor: 3.558

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.